About Retinoic acid receptor RXR-alpha
Retinoic acid receptor RXR-alpha (RXRA) is a protein
from Homo sapiens identified by UniProt accession
P19793, 462 residues long.
MolForge cross-references it against 0 known binders and
641 disease associations.
Target properties
| Protein name | Retinoic acid receptor RXR-alpha |
| UniProt accession | P19793 |
| Gene | RXRA |
| Organism | Homo sapiens |
| Length | 462 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (13)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (641)
Diseases linked to this target (Open Targets).
- psoriasis · score 0.59
- urinary bladder cancer · score 0.52
- sex hormone-binding globulin measurement · score 0.50
- Eczematoid dermatitis · score 0.50
- Cutaneous T-cell lymphoma · score 0.50
- neoplasm · score 0.48
- bilirubin measurement · score 0.46
- Constipation · score 0.46
- skin disease · score 0.45
- lymphoma · score 0.45
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P19793-F1 | alphafold | PREDICTED | 75.39 | — |
Amino-acid sequence (462 residues)
MDTKHFLPLD FSTQVNSSLT SPTGRGSMAA PSLHPSLGPG IGSPGQLHSP ISTLSSPING MGPPFSVISS PMGPHSMSVP TTPTLGFSTG SPQLSSPMNP VSSSEDIKPP LGLNGVLKVP AHPSGNMASF TKHICAICGD RSSGKHYGVY SCEGCKGFFK RTVRKDLTYT CRDNKDCLID KRQRNRCQYC RYQKCLAMGM KREAVQEERQ RGKDRNENEV ESTSSANEDM PVERILEAEL AVEPKTETYV EANMGLNPSS PNDPVTNICQ AADKQLFTLV EWAKRIPHFS ELPLDDQVIL LRAGWNELLI ASFSHRSIAV KDGILLATGL HVHRNSAHSA GVGAIFDRVL TELVSKMRDM QMDKTELGCL RAIVLFNPDS KGLSNPAEVE ALREKVYASL EAYCKHKYPE QPGRFAKLLL RLPALRSIGL KCLEHLFFFK LIGDTPIDTF LMEMLEAPHQ MT
Explore Retinoic acid receptor RXR-alpha with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets